Studies have shown that the ε4 variant of APOE is associated with an increased risk for Alzheimer’s disease (AD) [6,7,8,9], and approximately 40% of AD patients carry at least one ε4 allele [5,10]. Here, APOE is linked to Alzheimer disease.